Intestinal epithelial homeostasis is maintained by adult intestinal stem cells, which, alongside 31 Paneth cells, appear after birth in the neonatal period. We aimed to identify new regulators of 32 neonatal intestinal epithelial development by testing a small library of epigenetic modifier 33 inhibitors in Paneth cell-skewed organoid cultures. We found that Lysine-specific 34 demethylase 1A (Kdm1a/Lsd1) is absolutely required for Paneth cell differentiation. Lsd1-35 deficient crypts, devoid of Paneth cells, are still able to form organoids without a requirement 36 of exogenous or endogenous Wnt. Mechanistically, we find that LSD1 represses genes that 37 are normally expressed in fetal and neonatal epithelium. This gene profile is similar to what is 38 seen in repairing epithelium, and indeed, we find that Lsd1-deficient epithelium has superior 39 regenerative capacities after irradiation injury. In summary, we found an important regulator 40 of neonatal intestinal development and identified a druggable target to reprogram intestinal 41 epithelium towards a reparative state. 42
INTRODUCTION 43
The intestinal epithelium undergoes a dramatic change during the neonatal period. Crypt 44 formation occurs after birth together with the appearance of Paneth cells (PCs) and the 45 development of adult intestinal stem cells (ISCs). Adult ISCs rely on niche factors such as 46 maintenance (Degirmenci et al., 2018; Greicius et al., 2018; Shoshkes-Carmel et al., 2018), 48 whereas in vitro, it is PCs that are required to supply the necessary Wnt (Sato et al., 2011; 49 Durand et al., 2012; Kim et al., 2012; Farin et al., 2012) . In contrast, Wnt ligands or PCs are 50 dispensable for fetal organoid homeostasis (Fordham et al., 2013; Mustata et al., 2013) . Thus, 51 ISCs undergo a fetal-to-adult transition that includes a change in Wnt dependency. 52
53
Recently, the existence of bona fide fetal ISCs has been challenged by the finding that any 54 fetal epithelial cell can be or become an adult ISC as long as the appropriate environment is 55 supplied (Guiu et al., 2019) . This model fits nicely with studies showing that after injury, the 56 intestinal epithelium is temporarily reprogrammed into a fetal-like state that is needed for 57 proper repair Nusse et al., 2018; Gregorieff et al., 2015) . This, in turn, 58 complements work specifying that adult intestinal epithelial lineages can dedifferentiate to 59
give rise to new ISCs to rebuild the epithelium after injury (Tetteh et al., 2016; Yu et al., 60 2018; van Es et al., 2012; Buczacki et al., 2013) . In hindsight, these high levels of cell-fate 61 reversion make sense because the intestine is a common site for chemical and mechanical 62 challenges as well as the host for many putative pathogens. Nonetheless, it is not yet fully 63 understood how the fetal-to-adult ISC transition, or its reversal upon injury, is mediated, and 64 whether epithelial reprogramming can be targeted therapeutically. 65 66 Adult ISCs give rise to all intestinal epithelial subtypes. Unlike other stem cell systems, both 67 ISCs and differentiating intestinal epithelial cells have a similar chromatin state at lineage 68 defining genes, which allows for Notch-mediated lateral inhibition in ISC differentiation 69 (Kim et al., 2014) . However, the same group subsequently identified differences in open 70 chromatin distinguishing ISCs from secretory precursors, which was reversed upon 71 irradiation when these secretory precursors dedifferentiate into ISCs (Jadhav et al., 2017) . 72
Three groups separately identified a crucial role for the polycomb repressive complex 2 73 (PRC2) in maintaining crypt physiology (Jadhav et al., 2019; Koppens et al., 2016; 74 Chiacchiera et al., 2016) . In summary, although it is clear there is an important role for 75 certain epigenetic modifiers in intestinal epithelial biology, the role and importance of others remain undefined. Here we exploit the availability of chemical probes targeting epigenetic 77 modifiers (Scheer et al., 2018) , and combine it with intestinal organoid cultures (Sato et al., 78 2009 ), to identify the demethylase LSD1 as a critical regulator of crypt maturation including 79 PC differentiation. 80 81 RESULTS AND DISCUSSION 82
Identification of LSD1 as a regulator of Paneth cells 83
The intestinal epithelium undergoes a dramatic change during the neonatal period including 84 the appearance of Paneth cells (PCs). To study PC differentiation in organoids, we developed 85 a differentiation protocol (adapted from (Yin et al., 2013) ) using CHIR (GSK3 inhibitor) and 86 DAPT (g-secretase inhibitor) to activate Wnt and block Notch signalling, respectively (Fig. 87 S1A). CHIR-DAPT treatment led to a robust enrichment of Lysozyme + PCs by confocal 88 microscopy, mRNA, and protein expression compared to standard EGF, Noggin, and R-89 spondin 1 (ENR) organoid growing conditions (Fig. 1A, S1B ). Next, we tested chemical 90 probes targeting 18 methyltransferases and demethylases and identified the LSD1 inhibitor 91 GSK-LSD1 to consistently repress PC differentiation ( Fig. 1B, 1C , S1C, S1D, 92 Supplementary table 1 ). In support, GSK-LSD1 similarly affected PC differentiation in 93 organoids grown in ENR conditions ( Fig. 1D , S1E), and use of a different LSD1 inhibitor led 94 to a similar near loss of PCs ( Fig. S1F ). Consistent with the irreversible binding nature of 95 GSK-LSD1 to its target (Mohammad et al., 2015) , we found that upon withdrawal of GSK-96 LSD1, PCs re-appeared after 2 organoid splitting events ( Fig. 1E , S1G). 97 98
Inhibition of LSD1 renders Lgr5 + cells independent of niche-providing PCs in vitro. 99
PCs are crucial for adult small intestinal organoids as they supply niche factors to retain a 100 stem cell population, and normally, PC-devoid organoids only sustain growth upon Wnt 101 supplementation (Sato et al., 2011; Durand et al., 2012; Kim et al., 2012; Farin et al., 2012) . 102
To test the role of LSD1 in intestinal stem cells, we used Lgr5-EGFP derived organoids and 103 treated them with GSK-LSD1. We found that GSK-LSD1 treatment resulted in a 2-3 fold 104 increase in percentage of Lgr5 + cells (Fig. 1F, 1G ). Thus, GSK-LSD1 treatment expands the 105 Lgr5 + population and renders these cells independent of PC-derived niche factors such as 106 Wnt3 (Fig. S1H ). To test if only a selection or all PC genes are downregulated upon LSD1 107 inhibition, we performed RNA-seq on organoids treated with GSK-LSD1 for 24 h, between 108 day 1 and 2 after splitting, which we anticipate is right when PCs develop. We found a robust 109 downregulation of all PC specific genes (gene set from (Haber et al., 2017)) ( Fig. 1H ). In 110 contrast, 24 h GSK-LSD1 treatment did not lead to an expansion of the Lgr5 + population 111 ( Fig. 1I ). Thus, the expansion of Lgr5 + cells upon LSD1 inhibition does not precede or 112 outcompete PC loss and may be a separate event. Nevertheless, using a recently described 113 culture condition that allows PC differentiation in human organoids (Fujii et al., 2018) , we 114 found that GSK-LSD1 also blocks PC differentiation in human organoids while 115 simultaneously expanding the LGR5 + population ( Fig. 1J-L) . 116 117
Fig. 1 | Inhibition of LSD1 blocks PC differentiation and allows niche-independent expansion of ISCs. A,

118
Confocal images of Lysozyme and DAPI staining of ENR and CHIR-DAPT (CD protocol as in (S1A)) grown 119 organoids. B, Quantification of Lysozyme/Tubulin levels by western blot of organoids treated with indicated 120 inhibitors in CD conditions. Concentrations used can be found in supplementary table 1. Data is mean from 2 121 independent experiments (see Fig. S1C , D for raw data). C, Brightfield images and inserts of CD-grown 122 organoids with and without GSK-LSD1 (1 µM). Lyz1 expression relative to Hprt by qPCR. C&D, Arrows
LSD1 is required for PCs but not goblet or enteroendocrine cells in vivo 133
To test the role of LSD1 in vivo, we crossed Lsd1 f/f (Kerenyi et al., 2013) with Villin-Cre 134 (Marjou et al., 2004) mice to delete Lsd1 in intestinal epithelial cells specifically (KO mice). 135
Although these mice appear normal, we found that KO mice lack PCs throughout the small 136 intestine ( Fig. 2A, S1I ). We did observe that KO mice had 'escaper' crypts still expressing 137 LSD1, and LSD1 + crypts were positive for Lysozyme ( Fig. S2J ). Thus, these mice do not 138 completely lack PCs. Currently, two genes are known to be absolutely required for PC 139 differentiation in vivo; Sox9 and Atoh1 (Bastide et al., 2007; Yang et al., 2001) . We did not 140 observe differences in Sox9 expression ( Fig. 2A) , and, although we found fewer Atoh1 + cells 141 in KO epithelium ( Fig. 2A ), reduction of Atoh1 + cells unlikely causes a complete lack of PCs. 142
We reasoned that perhaps KO crypts are filled with PC precursors expressing Wnt3, however, 143 similar to GSK-LSD1 treated organoids, Wnt3 was markedly reduced in crypts of KO mice 144 crypts ( Fig. 2A ). Next, we examined other intestinal secretory lineages and found a reduction 145 of goblet cells, but equal numbers of enteroendocrine cells, comparing adult WT and KO 146 littermates ( Fig. 2B ). When we examined fetal and postnatal intestines of WT and KO 147 littermates, we found that the reduction in goblet cells emerges after developmental stage P7, 148 similar to when PCs start to develop ( Fig. 2C, 2D To test the role of LSD1 in ISCs in vivo, we used in situ hybridization (ISH) and antibody-155 based detection of the ISC marker Olfm4 in tissues of WT and KO mice. We found Olfm4 + 156 cells completely filling the bottom of crypts in KO mice, compared to the standard PC/ISC 157 pattern observed in WT crypts ( Fig. 2E, S1L ). In addition, all crypt-base cells in KO mice are 158 Ki67 + , suggesting that these Olfm4 + cells are proliferating ( Fig. S2L ). Atoh1 -/mice lack PCs, 159 and Atoh1 -/crypts do not sustain organoid growth without Wnt supplementation (Durand et 160 al., 2012) . In contrast, Lsd1 WT and KO crypts were equally able to form organoids, even in 161 the absence of PCs in KO organoids (Fig. 2F ). This led us to hypothesize that KO organoids 162 do not rely on endogenous Wnt. Indeed, blockage of Wnt signaling by the porcupine inhibitor 163 IWP-2, showed that treated KO organoids sustained growth unlike WT organoids ( Fig. 2G , 164 2H). Of note, IWP-2 distinctively reduced growth rate in KO organoids, which makes long-165 term expansion unfeasible, yet, after splitting there were still surviving KO organoids under 166 continuous IWP-2 treatment, and, LSD1 inhibitor treatment greatly increased splitting 167 efficiency ( Fig. S1I, S1J ). In contrast, both KO and WT organoids could not sustain growth 168 in medium lacking R-spondin 1 (Fig. 2G, 2H ). Thus, loss of LSD1 activity in ISCs renders 169 them not requiring (endogenous) Wnt for growth and even leads to expansion of this 170 population ( Fig. 1 ). However, GSK-LSD1 is not able to replace Wnt3A in the ability to form 171 organoids from single ISCs (Fig. 1I ). Although KO organoids resemble aspects of those 172 derived from fetal epithelium that also lack PCs (Fordham et al., 2013; Mustata et al., 2013) , 173 there are some key distinctions. Unlike fetal organoids, KO organoids cannot grow without 174 R-spondin 1. In addition, KO organoids form crypts, whereas fetal or Wnt-supplemented 175 organoids mainly grow as spheroids. 176
177
Our data thus suggests that adult KO epithelium is in between fetal and adult: KO organoids 178 do not rely on Wnt yet are unable to grow without R-spondin 1, and KO epithelium in vivo 179 lack PCs and have reduced GC numbers yet with crypts that have Olfm4 + ISCs. 180 Next, we sought to find the mechanism by which LSD1 controls intestinal epithelial biology. 194
We performed RNA-seq on FACS-sorted Epcam + small intestinal crypt cells from WT and 195 KO mice. We found 2564 up and 1522 down regulated genes (p-adj<0.1) in KO cells 196 compared to WT cells (Fig. 3A) . In support of our findings that there are Atoh1 + cells in KO crypts and the differential ability of Atoh1-KO and Lsd1-KO crypts to form organoids, we 198 found no shift towards an Atoh1 -/gene signature in the KO transcriptional profile ( Fig. S2A ) 199 (Kim et al., 2014) . To verify our gene expression profile, we tested a PC-specific gene 200 signature (Haber et al., 2017) , and, expectedly, found that this is repressed in KO crypts (Fig. 201 3B) . 202
203
A study reported that an LSD1-GFI1 complex was rapidly disturbed by LSD1 inhibitors, and 204 that the scaffolding role of LSD1 rather than its enzyme activity was most crucial (Maiques-205 Diaz et al., 2018) . Notably, Gfi1 -/mice have a near loss of PCs and ISCs, reduced goblet 206 cells, but more enteroendocrine cells (Shroyer et al., 2005; Sato et al., 2011) . When we 207 examined genes known to be repressed by GFI1 in intestinal epithelium, we indeed found 208 rapid and robust increase of Neurog3 and Neurod1, but not that of mature enteroendocrine 209 cell markers Chga and Chgb (Fig. 3C ). This is in accordance with equal enteroendocrine cells 210 in vivo in WT and KO mice ( Fig. 2C, S1K ). Together, this suggests that inhibition of LSD1 211 rapidly leads to enzyme-independent de-repression of GFI1-targeted enteroendocrine-212 progenitor markers, that in turn can limit PC differentiation (Shroyer et al., 2005) . 213
Furthermore, these enteroendocrine progenitors may take over the role of PCs in Notch-214 dependent crypt formation (van Es et al., 2019) . However, it does not explain the expansion 215 of ISCs, the complete loss of PCs, or the lack of expansion of mature ChgA + cells that we 216 observe in KO epithelium, which thus contradict a primarily GFI1-mediated mechanism. 217 218 Over the years, there have been various different intestinal stem cell and stem-cell like 219 populations described, either using genetic markers such as Lgr5 or Bmi1, or by techniques 220 such as label-retaining capacity and scRNA-seq (Yan et al., 2017; Buczacki et al., 2013; van 221 Es et al., 2012; Ayyaz et al., 2019; Muñoz et al., 2012) . To test if there was enrichment for a 222 certain stem cell type, we analyzed expression of defining genes for each population (Fig.  223 S2B, S2C), however, we did not find enrichment for any stem cell subtype including the 224 classical Lgr5 + ISC signature. Instead, we find enrichment of two fetal gene sets in the KO 225 transcriptional profile ( Fig. 3D ) Mustata et al., 2013) . Recently, two groups 226 elegantly identified and characterized a cellular repair state in the intestinal epithelium that is 227 fetal-like Nusse et al., 2018) . Indeed, two repair gene signatures from these 228 studies were also enriched in the KO transcriptional profile (Fig. 3D ). Yui et al. revealed that 229 the reparative state was mediated by YAP/TAZ . A separate YAP gene 230 signature was enriched in our KO transcriptional profile ( Fig. 3D) (Gregorieff et al., 2015) .
To test if YAP/TAZ is required for LSD1-mediated PC differentiation, we treated organoids 232 derived from mice lacking both Yap and the gene encoding for TAZ Wwtr1 (Vil-233 Cre;Yap f/f ;Wwtr1 f/f ) with GSK-LSD1 and found that PC differentiation was equally impaired 234 in WT and mutant organoids ( Fig. S2D ). However, we noted that approximately half of these 235 organoids contained Yap and Wwtr1 based on qPCR ( Fig. S2E ). We thus tested a second 236 model, deleting YAP/TAZ in an inducible manner (Vil-CreERT2; Yap f/f ;Wwtr1 f/f organoids). 237
Indeed, tamoxifen treatment led to near undetectable levels of both Yap and Wwtr1 (Fig.  238 S2F), impaired survival and led to an increase in PCs (Fig. 3E, 3F ), in accordance with 239 previous results (Azzolin et al., 2014; Gregorieff et al., 2015) . Strikingly, GSK-LSD1 240 treatment completely abrogated PC differentiation independently of YAP/TAZ (Fig. 3E, 3F ). 241
242
To distinguish fetal from postnatal intestinal epithelial development we performed RNA-seq 243 on embryonic (E) day 18.5, as well as postnatal (P) days 7 and P21 intestinal epithelium ( Fig.  244 S2G, S2H). Figure 3G shows how established cell lineage markers behave during 245 development. As expected, we observed a stepwise increase in ISC markers, an abrupt 246 appearance of PC genes at P21, and goblet and enteroendocrine gene expression at E18.5 and 247 P7 stages that only increases slightly at P21 (Fig. 3G ). This indeed supports our hypothesis 248 that KO mice have intestinal epithelium that is 'stuck' at a P7 stage, lacking PCs, with 249 reduced goblet cell and immature enteroendocrine cells, but with crypts containing ISC-like 250 cells. When we compared genes upregulated in KO crypts to different developmental stages 251 we see overlap with both E18.5 and P7 stages compared to P21 (Fig. 3H) . In a separate test, 252 we found enrichment by GSEA for our own fetal (E18vsP7) and neonatal (P7vsP21) cell differentiation (Agarwal et al., 2017; Whyte et al., 2012) . We did not observe major 269 differences in global H3K4me1/2 levels by immuno-histochemistry comparing escaper 270 LSD1 + crypts in KO tissue (Fig. S3A ). To assess if LSD1 mediates H3K4 demethylation, we 271 performed ChIP-seq for H3K4me1 and H3K4me2 comparing sorted WT and KO crypt cells. 272
Analysis of ChIP-seq for H3K4me1 identified 2059 sites with associated altered methylation 273 levels, of which the majority (1622) were enriched in KO crypts (Fig. 4A ). ChIP-seq of 274
H3K4me2 revealed a very similar pattern and the large majority of genes affected by LSD1 275 with gain of H3K4me2 were also significant in the analysis for H3K4me1 (Fig. 3A, 3B) . In 276 addition, most of these peaks are not in close proximity to TSS sites (Fig. S3B ). The top 300 277 genes associated with increased H3K4me1 levels in the KO, are overall enriched in the KO 278 transcriptional profile ( Fig. 4C ). Furthermore, using a high stringency (adj. p<0.01), we 279 combined our RNA-seq and H3K4me1 ChIP-seq data to establish a core list of 228 genes that 280 are mediated by the enzymatic activity of LSD1 (Table S2 ). Importantly, 84% of the 281 increased H3K4me1 peaks associated with these 228 genes are located outside the 2 kb 282 surrounding the TSS. This suggests that LSD1 would drive enhancer-mediated regulation of 283 these genes, which fits with a role generally associated with LSD1 (Whyte et al., 2012; 284 Agarwal et al., 2017) . Importantly, the LSD1 core signature is enriched in a transcriptional 285 profile comparing fetal with adult organoids ( Fig. 4D ). Thus, we propose 286 that LSD1 enzymatically represses genes that are required for maturation of intestinal 287 epithelium. 288 289 LSD1 controls genes separately from PRC2 290 Several groups have shown that EED, an essential component of the Polycomb Repressive 291
Complex 2 (PRC2), is essential for maintaining adult ISCs and crypts, likely by repressing 292 fetal and embryonic genes (Koppens et al., 2016; Jadhav et al., 2019; Chiacchiera et al., 293 2016 ). Indeed, EED controlled genes show a remarkable similar overlap with fetal and 294 neonatal genes as LSD1 controlled genes (Fig. 4E, 3H ). However, where EED KO epithelium 295 returns to a fetal and even embryonic state and mice become moribund (Jadhav et al., 2019) , 296 LSD1 KO mice retain an early-life postnatal stage and appear normal up to at least 1 year. 297
Fittingly, comparing the LSD1 core with the EED core (genes up in EEDKO crypts and 298 associated with H3K27me3 peaks (Koppens et al., 2016) ) revealed strikingly little overlap 299 between regulated genes (Fig. 4F ). Further analysis confirmed that also the majority of 300 putative LSD1-controlled H3K4me1 genes are not 'co-repressed' by the PRC2-mediated H3K27me3 (Fig. 4G) . Thus, this suggests that both LSD1 and PRC2 control fetal-like genes 302 but in an unrelated fashion. 303 with H3K4me1 and H3K4me2 peaks that were significantly higher in KO crypts compared to WT crypts. C, RNA-seq 307 analysis by GSEA of KO vs WT transcriptional profile on a gene set consisting of genes with associated 308 increased H3K4me1 levels in KO crypts. D, GSEA of LSD1 core gene list (228 genes) on a transcriptome data 309 set that compares fetal to adult organoids . E, Venn diagram of genes significantly higher 310 expressed in EEDKO compared with genes that are up in P7vs.P21 and E18vs.P21.F & G, Venn diagrams 311 comparing the LSD1 core, and the EED core (genes up in EED KO crypts AND have H3K27me3 associated 312 peak) as well as the genes associated with increased methylation levels in each separate group. 
LSD1 expression is downregulated during repair 317
We conclude that LSD1 represses fetal/neonatal genes in adult epithelium. A similar gene set 318 is re-activated after damage during the repair phase. Thus, we hypothesized that during repair 319 de-repression of LSD1-controlled fetal/neonatal genes would require LSD1 inactivation. 320 Therefore, we studied LSD1 expression after whole body irradiation (10 gy) and found that 321 LSD1 is lower expressed in large crypts that appear 3 days post irradiation, compared to 322 normal-sized crypts of naïve mice ( Fig. 5A ). Of note, this is opposite of the Hippo-transducer 323 YAP expression pattern (Fig. S3C) . In support, we assessed Lsd1 expression in a recently 324 described single cell RNA-seq experiment comparing crypt cells during homeostasis and 325 during active repair , and found a clear reduction in number of crypt cells 326 expressing Lsd1 (Fig. 5B) . In summary, Lsd1 is actively downregulated in the repair phase of 327 intestinal epithelium. 328 329 Lsd1-deficient epithelium has superior reparative capacity 330
The reparative-like features of KO epithelium prompted us to test if this would be beneficial 331 upon injury. We irradiated WT and KO mice with 10 Gy and we did not observe pathological 332 differences 6 days post treatment (Fig. 5C, S3D ). However, we did find an increase in crypt 333 length 3 days after injury, as measured by Ki67 + cells (Fig. 5D, 5E ). Of note, we found no 334 evidence of appearing PCs after injury in KO tissue (Fig. 5F ), but we did observe that the 335 Olfm4 + ISC zone similarly expanded as the Ki67 + crypts (Fig. 5F, 5G ). This suggests that KO 336 epithelium may be have better reparative capacities, but with this level of irradiation WT 337 epithelium is also able to recover after 6 days. Thus, we next irradiated mice with 16 Gy, 338 when WT mice are unable to recover by day 6, and in striking contrast, KO epithelium 339 regained crypt-villus structures and had lower pathology scores compared to WT epithelium 340 ( Fig. 5H, 5I, S3E, S3F ). Thus, KO epithelial tissue that have a pre-existing repairing profile 341 enhances repair in vivo after radiation injury. 342 343
Sustained inhibition of LSD1 renders human organoids fetal-like 344
Importantly, the role we find for LSD1 suppressing fetal/neonatal genes is the opposite of 345 what recently was found in skin, where inhibition of LSD1 led to increase of fate-determining 346 transcription factors and increase in differentiation, which was beneficial for treatment of 347 skin cancer (Egolf et al., 2019) . This is similar to what has been proposed for other cancer 348 types, including intestinal tumors in zebrafish, where LSD1 inhibition would lead to 349 differentiation and reduced tumor development (Maiques-Diaz et al., 2018; Rai et al., 2010) . 350
To test the translational potential of our findings, we performed a gene expression array of 351 GSK-LSD1 treated human organoids, and found that the LSD1 core and a fetal signature 352 were enriched in GSK-LSD1 treated human organoids (Fig. 6J) . 353
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METHODS
Animal work
Lgr5-EGFP-IRES-CreERT2 (stock no: 008875) mouse strain was obtained from Jackson Laboratories. Villin-Cre and Villin-CreERT2 (Marjou et al., 2004) were a kind gift from Sylvie Robine, Lsd1 f/f mice were a kind gift from Dr. Stuart Orkin (Kerenyi et al., 2013) . 
Crypt, IEC, and ISC isolation, mouse organoid cultures
Adult crypt isolation: Crypt, IEC, and ISC isolation, as well as organoid culture, were essentially done as described (Sato and Clevers, 2013) . For adult crypt isolation duodenum tissue was rinsed with ice-cold PBS, cut open longitudinally, and villi were scraped off.
Tissue was cut in ~2 mm pieces and washed 5 times with ice-cold PBS. Tissue pieces were incubated in 2 mM EDTA in ice-cold PBS for 30-60 minutes. Crypts were isolated from up to 10 fractions after pipetting up and down 5 times with PBS. To isolate single cells for sorting, crypts were incubated in TrypLE (ThermoFisher) at 37 °C for 20-45 minutes. Single cells were stained and sorted, DAPI-negative and Epcam-positive cells were used for RNAseq and ChIP-seq experiments. ISCs for clonal organoid outgrowth experiments were isolated by sorting DAPI-negative, GFP-high (top 5%) cells from Lgr5-EGFP mice.
E18.5/P7/P21 IEC isolation: Whole (E18.5) or proximal 10 cm (P7 and P21) small intestines were isolated and flushed with ice cold PBS when possible (P21). Small intestines were opened longitudinally (P21 and P7) and cut into small pieces that were washed with ice-cold PBS, and incubated with 2 mM EDTA in ice-cold PBS for 30 min. Whole epithelium was isolated by collecting all fractions, which was used directly for RNA isolation, for ChIP fractions were made single cell using TrypLE (ThermoFisher) and sorted as described.
Organoid cultures: Organoids were grown and maintained in 'basal crypt medium' (Advanced DMEM/F12 medium supplemented with penicillin/streptomycin, 10 mM HEPES, 2 mM Glutamax, N2 (Thermo Fisher, 17502048), B-27 (Thermo Fisher, 17504044)) supplemented with N-acetyl-L-cysteine (Sigma, A7250), 50 ng/ml murine EGF [ThermoFisher, PMG8041], 20% R-spondin 1s conditioned medium (CM) (kind gift from Dr. Calvin Kuo), and 10% Noggin-CM (kind gift from Dr. Hans Clevers). For ISC clonal experiments, in the first 48 h after seeding, the medium was supplemented with Rock inhibitor (Y-27632) and Jagged-1 peptide (amino-acid sequence CDDYYYGFGCNKFCRPR, made in house, peptide synthesized as described (Bolscher et al., 2011) ), 33% Wnt3-CM (kind gift from Dr. Hans Clevers) served as control. Medium was renewed every other day.
For passaging, organoids cultures were washed, and matrigel and organoids were disrupted mechanically by strong pipetting, centrifuged at 200g, 5 min at 4 °C and resuspended in Matrigel to re-plate. Imaging of live organoids was done using an EVOS FL Auto 2.
Structural Genomics Consortium supplied the inhibitors for the screen (www.thesgc.org), all of which are commercially available, concentrations are listed in Supplementary Table 1 .
Additionally, CHIR99021 (3 µM), IWP-2 (2 µM), VPA (1 mM) and DAPT (10 µM) were used. Human small intestine samples were obtained from patients undergoing elective surgery at Tokyo University Hospital with written informed consent. This was approved by the ethical committee (No. G3553- (7)). Crypt isolation and optimized organoid culture conditions that allow PC differentiation was done essentially as described 5,6 . In short, stroma was physically removed and the remaining epithelium was cut into 1-mm 3 pieces, washed at least 5 times in ice cold PBS, and incubated in 2.5 mM EDTA in ice cold PBS for 1 hour. Isolated crypts were then suspended in Matrigel and seeded in 48-well plates. Domes of polymerized Matrigel were given the refined medium consisting of 'basal crypt medium' (see above)
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supplemented with 10 nM gastrin I (Sigma-Aldrich), 1 mM N-acetylcysteine (Sigma-Aldrich), 100 ng/ml recombinant mouse Noggin (PeproTech), 50 ng/ml recombinant mouse EGF (Thermo Fisher Scientific), 100 ng/ml recombinant human IGF-1 (BioLegend), 50 ng/ml recombinant human FGF-basic (FGF-2) (Peprotech), 1 mg/ml recombinant human R-spondin1 (R&D), 500 nM A83-01 (Tocris) and 50% Afamin-Wnt-3A serum-free conditioned medium.
LGR5-iCaspase9-tdTomato organoids were made previously (Fujii et al., 2018) . For staining, organoids were isolated from Matrigel using Cell Recovery Solution (Corning) and fixed in 4% paraformaldehyde for 20 min at room temperature. Next, organoids were washed with PBS, and permeabilized with 0.2% Triton X-100 in PBS for 20 min at room temperature. Blocking was done using Power Block Universal Blocking Reagent (BioGenex) for 20 min at room temperature, and rabbit anti-Lysozyme antibody (A0099, DAKO 1:1000 ( Fig. 1h) , GTX72913, GeneTex, 1:200 (Fig. 2f) ) and anti-RFP (600-401-379, Rockland 1:500) was incubated overnight at 4 °C. Organoids were washed 3 times with PBS, and secondary antibody incubation was done for 30 min at room temperature. Nuclear counterstaining was done simultaneously with secondary antibody incubation using Hoechst 33342 (Thermo Fisher Scientific). Stained organoids were suspended in 1 drop of ProLong Diamond Antifade Mountant (Thermo Fisher Scientific) and mounted onto a 35-mm glass bottom dish. Images were captured using a confocal microscope (SP8, Leica).
Immunohistochemical staining of intestinal tissue
For immunohistochemical staining and imaging, tissues were harvested and fixed in swiss rolls. After fixation in formalin, tissues were embedded in paraffin and cut in 4 µm sections.
Paraffin sections were rehydrated and peroxidase activity was blocked in 3% hydrogen peroxide. Antigen retrieval was performed in citrate buffer pH6. Sections were stained overnight with primary antibodies against Ki67 (1:500, Thermo Scientific MA5-14520), Lysozyme (1:750, Dako A0099), Sox9 (1:200, Millipore), LSD1 (1:200, Cell Signalling 2184S), H3K4me1 (1:100, Cell Signaling 9723) and H3K4me2 (1:1500, Cell Signalling 9725). The sections were washed in TBS and Tween-20 and stained for 1 hour with HRPlabelled secondary antibody (Dako K4003). The staining was developed with diaminobenzidine (DAB) chromogenic substrate (Dako K5007) and mounted with Glycergel mounting medium (Dako C056330). Tissues were imaged using a Nikon eclips Ci-L microscope.
Immunofluorescence staining of intestinal tissue and organoids
For immunofluorescence labeling and imaging, tissues (first 5 cm of duodenum) were harvested and fixed in swiss rolls. After fixation in formalin, tissues were paraffin embedded and cut in 4 µm sections. Briefly, paraffin sections were treated as before for IHC, and after antigen retrieval were blocked and permeabilized in PBS with TX-100 0.2%, Normal Goat Serum (NGS) 2%, BSA 1% and Tween-20 0.05%. Sections were then stained overnight in the same blocking buffer with primary antibodies against GFP (1:2000 Abcam 13970), YAP
(1:200 Cell Signaling Technologies 14074S), OLFM4 (1:200 Cell Signalling 39141S) or LSD1 (1:200 Cell Signaling Technologies 2184S). Tissues were then incubated with the corresponding secondary antibodies for 3 hours (1:500 Alexa Fluor), Rhodamine-labeled UEA1 (5 µg/ml Thermo Fisher Scientific NC9290135) and Hoechst 33342 (1:10,000).
Washes were performed with PBS + Tween-20 0.1%.
For organoid staining, organoids were grown in Matrigel on eight-chamber μ-slides (Ibidi 80826) and fixed after exposition to the specific treatments in PBS containing 4% paraformaldehyde (pH 7.4) and 2% sucrose for 20-30 min, permeabilized (PBS, 0.2% Triton X-100) and blocked (PBS-Triton X-100 0.2%, 2% NGS, 1% BSA). Primary antibodies against the following antigens were used, diluted in the same blocking buffer: Lysozyme
(1:500, Dako A0099), GFP (1:2000 Abcam 13970) and LSD1 (1:400 Cell Signaling Technologies 2184S) overnight at 4°C with slow agitation. Rhodamine-labeled UEA1 (5 µg/ml Thermo Fisher Scientific NC9290135) and Hoechst 33342 (1:10,000) were used to stain secretory cells and nuclei respectively together with the corresponding secondary antibodies (1:500 Alexa Fluor) and incubated overnight in PBS with 0.2% Triton X-100, 1% NGS and 0.5% BSA at 4°C. Tissue sections and organoids were both mounted using Fluoromount G (ThermoFisher Scientific, 00-4958-02) and imaged with a Zeiss 510 Meta Live or a Zeiss LSM880 confocal microscope, using 20x and 40x objective lens.
In situ hybridization
In situ hybridization was performed on FFPE tissues using RNAscope® 2.5 HD BROWN reagent kit (Advanced Cell Diagnostics (ACD) 322371). Tissue sections (4µm) were deparaffinised with Neoclear and 100% ethanol. The slides were pretreated with hydrogen peroxide for 10 minutes, target antigen retrieval reagent for 15 minutes, and protease plus reagent for 30 minutes (ACD 322300 and 322000). The sections were hybridized with probes for Mm-Wnt3 (ACD 312241), Mm-Olfm4 (ACD 311831), Mm-Atoh1 (ACD 408791), positive control Mm-Ppib (ACD 313911) and negative control Mm-DapB (ACD 310043).
For amplification and chromogenic detection the 2.5 HD Detection Reagents BROWN kit (ACD 322310) was used. The slides were counterstained with hematoxylin, dehydrated and mounted with Neomount (Merck 109016). Tissues were imaged using a Nikon eclips Ci-L microscope.
